Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
Authors
Keywords
-
Journal
Oncogenesis
Volume 5, Issue 5, Pages e226-e226
Publisher
Springer Nature
Online
2016-05-30
DOI
10.1038/oncsis.2016.32
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ROR1 sustains caveolae and survival signalling as a scaffold of cavin-1 and caveolin-1
- (2016) Tomoya Yamaguchi et al. Nature Communications
- Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis
- (2015) Tsz-Lun Yeung et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Elevated β-catenin activity contributes to carboplatin resistance in A2780cp ovarian cancer cells
- (2015) Samir H. Barghout et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Efficient molecular subtype classification of high-grade serous ovarian cancer
- (2015) Huei San Leong et al. JOURNAL OF PATHOLOGY
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling
- (2015) Lauren A. Baldwin et al. Oncotarget
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer
- (2014) C.E. Ford et al. GYNECOLOGIC ONCOLOGY
- Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling
- (2014) C. Henry et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
- (2014) Gottfried E. Konecny et al. JNCI-Journal of the National Cancer Institute
- Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer
- (2014) Q H Miow et al. ONCOGENE
- Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy
- (2014) Suping Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ROR1 expression correlated with poor clinical outcome in human ovarian cancer
- (2014) Huilin Zhang et al. Scientific Reports
- The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer
- (2013) Yan Ni Loh et al. BMC CANCER
- Molecular Signatures of Epithelial Ovarian Cancer: Analysis of Associations with Tumor Characteristics and Epidemiologic Risk Factors
- (2013) J. M. Schildkraut et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Targeting ROR1 Inhibits Epithelial-Mesenchymal Transition and Metastasis
- (2013) B. Cui et al. CANCER RESEARCH
- WNT5A is a Key Regulator of the Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties in Human Gastric Carcinoma Cells
- (2013) Maki Kanzawa et al. PATHOBIOLOGY
- The Wnt Gatekeeper SFRP4 Modulates EMT, Cell Migration and Downstream Wnt Signalling in Serous Ovarian Cancer Cells
- (2013) Caroline E. Ford et al. PLoS One
- Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2
- (2013) M. P. O'Connell et al. Cancer Discovery
- EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
- (2012) Alexandria M Haslehurst et al. BMC CANCER
- NKX2-1/TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma
- (2012) Tomoya Yamaguchi et al. CANCER CELL
- Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition
- (2011) Dayong Ren et al. GENES TO CELLS
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma
- (2009) M P O’Connell et al. ONCOGENE
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
- (2009) Nawneet K. Kurrey et al. STEM CELLS
- Enhancing the efficacy of cisplatin in ovarian cancer treatment – could arsenic have a role
- (2009) C William Helm et al. Journal of Ovarian Research
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search